| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1035134510 |
| P356 | DOI | 10.1186/S13046-016-0398-8 |
| P932 | PMC publication ID | 4957876 |
| P698 | PubMed publication ID | 27448598 |
| P50 | author | Fabrizio Ensoli | Q55069671 |
| Valentina Bordignon | Q56450971 | ||
| Beatrice Macchi | Q58885095 | ||
| Francesca Marino Merlo | Q59683590 | ||
| P2093 | author name string | Antonio Mastino | |
| Paola Cordiali-Fei | |||
| Andrea Cottarelli | |||
| Caterina Frezza | |||
| Giampietro Ravagnan | |||
| Maria Pia Fuggetta | |||
| Stefania Ciafrè | |||
| P2860 | cites work | Molecular Mechanisms of HTLV-1 Cell-to-Cell Transmission | Q26752562 |
| Resveratrol prevents EBV transformation and inhibits the outgrowth of EBV-immortalized human B cells | Q28484266 | ||
| Susceptibility of primary HTLV-1 isolates from patients with HTLV-1-associated myelopathy to reverse transcriptase inhibitors. | Q34223814 | ||
| IL-17 in Chronic Inflammation: From Discovery to Targeting | Q34512003 | ||
| Expansion in CD39⁺ CD4⁺ immunoregulatory t cells and rarity of Th17 cells in HTLV-1 infected patients is associated with neurological complications. | Q34587031 | ||
| Human T-cell lymphotropic virus: a model of NF-κB-associated tumorigenesis | Q35090534 | ||
| Resveratrol inhibits enterovirus 71 replication and pro-inflammatory cytokine secretion in rhabdosarcoma cells through blocking IKKs/NF-κB signaling pathway. | Q35097865 | ||
| The pharmacology of resveratrol in animals and humans | Q35555258 | ||
| Effect of TNF-α production inhibitors on the production of pro-inflammatory cytokines by peripheral blood mononuclear cells from HTLV-1-infected individuals | Q35663886 | ||
| Inhibition of nitric oxide and inflammatory cytokines in LPS-stimulated murine macrophages by resveratrol, a potent proteasome inhibitor | Q36086859 | ||
| Resveratrol: French paradox revisited | Q36099455 | ||
| HTLV tax: a fascinating multifunctional co-regulator of viral and cellular pathways | Q36434903 | ||
| Rapid dissemination of human T-lymphotropic virus type 1 during primary infection in transplant recipients | Q36446222 | ||
| HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP) inflammatory network | Q37239979 | ||
| Antiviral activity of resveratrol | Q37674667 | ||
| Clinical trials of resveratrol | Q37831946 | ||
| New insight into the oncogenic mechanism of the retroviral oncoprotein Tax. | Q38032236 | ||
| Inflammatory manifestations of HTLV-1 and their therapeutic options | Q38262169 | ||
| Resveratrol and inflammation: Challenges in translating pre-clinical findings to improved patient outcomes | Q38316214 | ||
| Tax protein of human T-cell leukaemia virus type 1 induces interleukin 17 gene expression in T cells | Q38339637 | ||
| The biology behind interleukin-6 targeted interventions | Q38692151 | ||
| The diversity of the structure and genomic integration sites of HTLV-1 provirus in MT-2 cell lines | Q38789112 | ||
| High production of interferon gamma but not interleukin-2 by human T-lymphotropic virus type I-infected peripheral blood mononuclear cells | Q39044887 | ||
| Increased sialyl Lewis(x) antigen-positive cells mediated by HTLV-1 infection in peripheral blood CD4(+) T lymphocytes in patients with HTLV-1-associated myelopathy | Q39117554 | ||
| Demonstration of human T lymphotropic virus type I (HTLV-I) tax-specific CD8+ lymphocytes directly in peripheral blood of HTLV-I-associated myelopathy/tropical spastic paraparesis patients by intracellular cytokine detection | Q39149927 | ||
| Resveratrol inhibits Epstein Barr Virus lytic cycle in Burkitt's lymphoma cells by affecting multiple molecular targets. | Q39277160 | ||
| Inhibition of herpes simplex virus infection by oligomeric stilbenoids through ROS generation | Q39348464 | ||
| Modulation of T cell responses in HTLV-1 carriers and in patients with myelopathy associated with HTLV-1. | Q39430207 | ||
| Proviral load and the balance of serum cytokines in HTLV-1-asymptomatic infection and in HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). | Q39487423 | ||
| Distinct roles of transforming growth factor-beta-activated kinase 1 (TAK1)-c-Rel and interferon regulatory factor 4 (IRF4) pathways in human T cell lymphotropic virus 1-transformed T helper 17 cells producing interleukin-9. | Q39557718 | ||
| Resveratrol exhibits a strong cytotoxic activity in cultured cells and has an antiviral action against polyomavirus: potential clinical use | Q39830593 | ||
| Effect of resveratrol on proliferation and telomerase activity of human colon cancer cells in vitro. | Q40242178 | ||
| In vitro antitumour activity of resveratrol in human melanoma cells sensitive or resistant to temozolomide | Q40548832 | ||
| Resveratrol Induces Downregulation in Survivin Expression and Apoptosis in HTLV-1-Infected Cell Lines: A Prospective Agent for Adult T Cell Leukemia Chemotherapy | Q40649653 | ||
| Array-based ELISAs for high-throughput analysis of human cytokines | Q40791002 | ||
| In vitro infection of CD4+ T lymphocytes with HTLV-I generates immortalized cell lines coexpressing lymphoid and myeloid cell markers | Q40972112 | ||
| SIRT1 Suppresses Human T-Cell Leukemia Virus Type 1 Transcription | Q41170140 | ||
| Resveratrol suppresses cell proliferation via inhibition of STAT3 phosphorylation and Mcl-1 and cIAP-2 expression in HTLV-1-infected T cells | Q42265002 | ||
| NF-kappaB inhibitory action of resveratrol: a probable mechanism of neuroprotection in experimental diabetic neuropathy | Q43138461 | ||
| Effects of resveratrol on human immune cell function | Q43838059 | ||
| Cytokine profile and immunomodulation in asymptomatic human T-lymphotropic virus type 1-infected blood donors | Q45736944 | ||
| Resveratrol inhibits phorbol ester-induced expression of COX-2 and activation of NF-kappaB in mouse skin by blocking IkappaB kinase activity | Q46941211 | ||
| IL-17 stimulates the production and expression of proinflammatory cytokines, IL-beta and TNF-alpha, by human macrophages | Q74412124 | ||
| Anti-inflammatory effect of resveratrol and polydatin by in vitro IL-17 modulation | Q83520064 | ||
| P4510 | describes a project that uses | ImageJ | Q1659584 |
| P433 | issue | 1 | |
| P921 | main subject | Human T-lymphotropic virus 1 | Q1280388 |
| P304 | page(s) | 118 | |
| P577 | publication date | 2016-07-22 | |
| P1433 | published in | Journal of Experimental & Clinical Cancer Research | Q13739415 |
| P1476 | title | Downregulation of proinflammatory cytokines in HTLV-1-infected T cells by Resveratrol | |
| P478 | volume | 35 |
Search more.